Heart cell DNA tested for better diagnosis of rare condition
NCT ID NCT03177018
First seen Dec 16, 2025 · Last updated May 15, 2026 · Updated 18 times
Summary
This study looked at whether DNA can be taken from heart muscle cells during a routine heart mapping procedure to help diagnose arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare heart condition. Researchers tested 34 adults to see if they could get good-quality DNA from these cells. The goal was to improve diagnosis, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardiology-rytmology service
Paris, France
-
University Hospital Toulouse - Cardiology Department
Toulouse, 31000, France
Conditions
Explore the condition pages connected to this study.